St. Jude expands European TAVI trial to include larger valves

February 4, 2013 by MassDevice staff

St. Jude Medical expands a European transcatheter aortic valve implantation study to include a larger 25 mm valve in treatment of patients with severe aortic stenosis.

St. Jude Medical's Portico heart valve

St. Jude Medical (NYSE:STJ) researchers implanted the 1st patient with a larger-sized Portico transcatheter aortic valve as part of the medical device maker's ongoing Portico TF EU trial.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.